Proteome analysis in adipose tissue of ob/ob mice in response to chitosan oligosaccharides treatment

Biotechnology and Bioprocess Engineering

Volumn 15, Issue 4, 2010, Pages 559-571

  Rahman, Md Atiar ^a   Kumar, Suresh G ^a   Yun, Jong Won ^a  

^a Daegu University   (South Korea)

Author keywords

Adipocyte proteome; Adipokines; Adipose tissue; Chitosan oligosaccharides; Obesity

Indexed keywords

ADIPOKINES; ADIPOSE TISSUE; CHITOSAN OLIGOSACCHARIDES; OBESITY; PROTEOMES;

ANIMALS; CHITIN; CHITOSAN; GENE EXPRESSION; MOLECULAR WEIGHT; OLIGOSACCHARIDES; PROTEINS;

NUTRITION;

ADIPOCYTE PROTEIN 2; ADIPOCYTOKINE; ALDEHYDE REDUCTASE; AQUAPORIN 7; ARGININOSUCCINATE LYASE; CELL CYCLE PROTEIN 37; CHITOSAN DERIVATIVE; CHITOSAN OLIGOSACCHARIDE; COLLAGEN TYPE 18; ENOYL COENZYME A HYDRATASE; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 90; INDOLEAMINE 2,3 DIOXYGENASE; INITIATION FACTOR 5A; INTERLEUKIN 6; KARYOPHERIN BETA; KINESIN; MYOSIN; NUCLEOSIDE DIPHOSPHATE KINASE; ORNITHINE OXOACID AMINOTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEASOME; PROTEIN; PROTEOME; RETINOIC ACID BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIMENTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPIDIDYMIS FAT; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TREATMENT RESPONSE; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ANIMALIA; MUS;

EID: 79953881803     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12257-009-3135-8     Document Type: Article

References (81)

1. Grundy, S. M. (2004) Obesity, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 89:2595-2600. (Pubitemid 38766337)
2. Kopelman, P. G. (2000) Obesity as a medical problem. Nature 404:635-643. (Pubitemid 30205068)
3. Moller, D. E. and K. D. Kaufman (2005) Metabolic syndrome: A clinical and molecular perspective. Annu. Rev. Med. 56:45-62. (Pubitemid 40299773)
4. Chaldakov, G. N., I. S. Stankulov, M. Hristova, and P. I. Ghenev (2003) Adipobiology of disease: Adipokines and adipokines-targeted pharmacology. Curr. Pharm. Des. 9:1023-1031. (Pubitemid 36443203)
5. Kershaw, E. E. and J. S. Flier (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89:2548-2556. (Pubitemid 38766330)
6. Wassink, A. M., J. K. Olijhoek, and F. L. Visseren (2007) The metabolic syndrome: metabolic changes with vascular consequences. Eur. J. Clin. Invest. 37:8-17. (Pubitemid 44934767)
7. Ajjan, R. A. and P. J. Grant (2006) Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents. Diab. Vasc. Dis. Res. 3:147-158. (Pubitemid 44902480)
8. Weigle, D. S. (2003) Pharmacological therapy of obesity: Past, present, and future. J. Clin. Endocrinol. Metab. 88:2462-2469. (Pubitemid 36724410)
9. Huang, C., Y. Zhang, Z. Gong, X. Sheng, Z. Li, W. Zhang, and Y. Qin (2006) Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR gamma pathway. Biochem. Biophys. Res. Commun. 348:571-578. (Pubitemid 44209153)
10. Jeon, T., S. G. Hwang, S. Hirai, T. Matsui, H. Yano, T. Kawada, B. O. Lim, and D. K. Park (2004) Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells. Life Sci. 75:3195-3203. (Pubitemid 39361176)
11. Kim, J. H., D. H. Hahm, D. C. Yang, J. H. Kim, H. J. Lee, and I. Shim (2005) Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. J. Pharmacol. Sci. 97:124-131. (Pubitemid 40313108)
12. Ono, Y., E. Hattori, Y. Fukaya, S. Imai, and Y. Ohizumi (2006) Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J. Ethnopharmacol. 106:238-244. (Pubitemid 43766196)
13. Kumar, M. N. V. (2000) A review of chitin and chitosan applications. React. Funct. Polym. 46:1-27. (Pubitemid 33763425)
14. Pae, H. O., W. G. Seo, N. Y. Kim, G. S. Oh, G. E. Kim, Y. H. Kim, H. J. Kwak, Y. G. Yun, C. D. Jun, and H. T. Chung (2001) Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer. Leuk. Res. 25:339-346.
15. Yoon, H. J., M. E. Moon, H. S. Park, S. Y. Im, and Y. H. Kim (2007) Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem. Biophys. Res. Commun. 358:954-959. (Pubitemid 46802483)
16. Lee, J. H., D. H. Lee, J. H. Son, J. K. Park, and S. K. Kim (2005) Optimization of chitosan-alginate encapsulation process using pig hepatocytes for development of bioartificial liver. J. Microbiol. Biotechnol. 15:7-13.
17. Singla, A. K. and M. Chawla (2001) Chitosan: Some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 53:1047-1067. (Pubitemid 32754936)
18. y mice. Biol. Pharm. Bull. 25:188-192. (Pubitemid 39592102)
19. Sumiyoshi, M. and Y. Kimura (2006) Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet longterm in mice. J. Pharm. Pharmacol. 58:201-207. (Pubitemid 43164276)
20. Houseknecht, K. L., C. A. Baile, R. L. Matteri, and M. E. Spurlock (1998) The biology of leptin: A review. J. Anim. Sci. 76:1405-1420. (Pubitemid 128439681)
21. Van den Hoek, A. M., B. Teusink, P. J. Voshol, L. M. Havekes, J. A. Romijn, and H. Pijl (2008) Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. J. Neuroendocrinol. 20:120-127. (Pubitemid 350239156)
22. Aebersold, R. and M. Mann (2003) Mass spectrometry-based proteomics. Nature 422:198-207. (Pubitemid 36362757)
23. Barceló-Batllori, S., H. Corominola, M. Claret, I. Canals, J. Guinovart, and R. Gomis (2005) Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats. Proteomics 18:4927-4935. (Pubitemid 43016911)
24. Rahman, A., S. G. Kumar, S. W. Kim, H. J. Hwang, Y. M. Baek, S. H. Lee, H. S. Hwang, Y. H. Shon, K. S. Nam, and J. W. Yun (2008) Proteomic analysis for inhibitory effect of chitosan oligosaccharides on 3T3-L1 adipocyte differentiation. Proteomics 8:569-581. (Pubitemid 351252014)
25. Adachi, J., C. Kumar, Y. Zhang, and M. Mann (2007) In-depth Analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol. Cell. Proteomics. 6:1257-1273. (Pubitemid 47099234)
26. Choi, K. L., Y. Wang, C. A. Tse, K. S. Lam, G. J. Cooper, and A. Xu (2004) Proteomic analysis of adipocyte differentiation: Evidence that α2 macroglobulin is involved in the adipose conversion of 3T3 L1 preadipocytes. Proteomics 4:1840-1848. (Pubitemid 38738338)
27. Kratchmarova, I., D. E. Kalume, B. Blagoev, P. E. Scherer, A. V. Podtelejnikov, H. Molina, P. E. Bickel, J. S. Andersen, M. M. Fernandez, J. Bunkenborg, P. Roepstorff, K. Kristiansen, H. F. Lodish, M. Mann, and A. Pandey (2002) A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics 1:213-222.
28. Lanne, B., B. Dahllöf, C. Lindahl, K. Ebefors, I. Kanmert, H. V. Bahr, T. Miliotis, A. C. Nyström, G. Arnerup, I. Paulsons, S. Kerb, and N. Oakes (2006) PPARα and PPARγ regulation of liver and adipose proteins in obese and dyslipidemic rodents. J. Prot. Res. 5:1850-1859. (Pubitemid 44232698)
29. Lee, H. K., B. H. Lee, S. A. Park, and C. W. Kim (2006) The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two-dimensional gel electrophoresis. Proteomics 6:1223-1229.
30. Renes, J., F. Bouwman, J. P. Noben, C. Evelo, J. Robben, and E. Mariman (2005) Protein profiling of 3T3-L1 adipocyte differentiation and (tumor necrosis factor α-mediated) starvation. Cell. Mol. Life Sci. 62:492-503. (Pubitemid 40379239)
31. Schmid, G. M., V. Converset, N. Walter, M. V. Sennitt, K. Y. Leung, H. Byers, M. Ward, D. F. Hochstrasser, M. A. Cawthorne, and J. C. Sanchez (2004) Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics 4:2270-2282. (Pubitemid 39025327)
32. Welsh, G. I., M. R. Griffiths, K. J. Webster, M. J. Page, and J. M. Tavare (2004) Proteome analysis of adipogenesis. Proteomics 4:1042-1051. (Pubitemid 38445962)
33. Cho, E. J., M. A. Rahman, S. W. Kim, Y. M. Baek, H. J. Hwang, J. Y. Oh, H. S. Hwang, S. H. Lee, and J. W. Yun (2008) Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J. Microbiol. Biotechnol. 18:80-87.
34. Kumar, S. G., M. A. Rahman, S. H. Lee, H. S. Hwang, H. A. Kim, and J. W. Yun (2009) Plasma proteome analysis for antiobesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9:2149-2162.
35. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
36. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann (1996) Mass spectrometric sequencing of proteins from silver stained gels. Anal. Chem. 68:850-858.
37. Han, L. K., Y. Kimura, and H. Okuda (1999) Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 23:174-179. (Pubitemid 29057513)
38. Flachs, P., V. Mohamed-Ali, O. Horakova, M. Rossmeisl, M. J. Hosseinzadeh-Attar, M. Hensler, J. Ruzickova, and J. Kopecky (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49:394-397. (Pubitemid 43185410)
39. Gault, V. A., P. L. McClean, R. S. Cassidy, N. Irwin, and P. R. Flatt (2007) Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia 50:1752-1762. (Pubitemid 47036655)
40. Weisberg, S. P., R. Leibel, and D. V. Tortoriello (2008) Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinol. 149:3549-3558. (Pubitemid 351919581)
41. Costantino, L., G. Rastelli, P. Vianello, G. Cignarella, and D. Barlocco (1999) Diabetes complications and their potential prevention: Aldose reductase inhibition and other approaches. Med. Res. Rev. 19:3-23. (Pubitemid 29006576)
42. Unoki, H., H. Bujo, S. Yamagishi, M. Takeuchi, T. Imaizumi, and Y. Saito (2007) Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diab. Res. Clin. Pract. 76:236-244. (Pubitemid 46400134)
43. Brandacher, G., E. Hoeller, D. Fuchs, and H. G. Weiss (2007) Chronic immune activation underlies morbid obesity: Is IDO a key player? Curr. Drug. Metab. 8:289-295. (Pubitemid 46621678)
44. Brandacher, G., C. Winkler, F. Aigner, H. Schwelberger, K. Schroecksnadel, R. Margreiter, D. Fuchs, and H. G. Weiss (2006) Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes. Surg. 16:541-548. (Pubitemid 43781036)
45. Young, J. C., V. R. Agashe, K. Siegers, and F. U. Hartl (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell. Biol. 5:781-791. (Pubitemid 39336272)
46. Kurucz, I., A. Morva, A. Vaag, K. Eriksson, X. Huang, L. Groop, and L. Koranyi (2002) Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 51:1102-1109. (Pubitemid 34438356)
47. Ozcan, U., Q. Cao, E. Yilmaz, A. H. Lee, N. N. Iwakoshi, E. Ozdelen, G. Tuncman, C. Gorgun, L. H. Glimcher, and G. S. Hotamisligil (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461. (Pubitemid 39372439)
48. Teichert-Kuliszewska, K., B. S. Hamilton, D. A. Roncari, J. L. Kirkland, W. S. Gillon, M. Deitel, and C. H. Hollenberg (1996) Increasing vimentin expression associated with differentiation of human and rat preadipocytes. Int. J. Obes. Relat. Metab. Disord. 3:108-113.
49. Marchesan, D., M. Rutberg, L. Andersson, L. Asp, T. Larsson, J. Borén, B. R. Johansson, and S. O. Olofsson (2003) A phospholipase D-dependent process forms lipid droplets containing caveolin, adipocyte differentiation-related protein, and vimentin in a cell-free system. J. Biol. Chem. 278:27293-27300. (Pubitemid 36876887)
50. Schwarz, E. J., M. J. Reginato, D. Shao, S. L. Krakow, and M. A. Lazar (1997) Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription. Mol. Cell. Biol. 17:1552-1561. (Pubitemid 27097385)
51. MacDougald, O. A. and M. D. Lane (1995) Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64:345-373.
52. MacDougald, O. A. and C. F. Burant (2005) Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporter. Proc. Natl. Acad. Sci. USA. 102:10759-10760. (Pubitemid 41105935)
53. Reshef, L., Y. Olswang, H. Cassuto, B. Blum, C. M. Croniger, S. C. Kalhan, S. M. Tilghman, and R. W. Hanson (2003) Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem. 278:30413-30416. (Pubitemid 36994541)
54. Hibuse, T., N. Maeda, T. Funahashi, K. Yamamoto, A. Nagasawa, W. Mizunoya, K. Kishida, K. Inoue, H. Kuriyama, T. Nakamura, T. Fushiki, S. Kihara, and I. Shimomura (2005) Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc. Natl. Acad. Sci. USA. 102:10993-10998. (Pubitemid 41105981)
55. Fruhbeck, G. (2005) Obesity: Aquaporin enters the picture. Nature 438:436-437. (Pubitemid 41742005)
56. Fruhbeck, G., V. Catalan, J. Gomez-Ambrosi, and A. Rodriguez (2006) Aquaporin and glycerol permeability as novel obesity drug-target pathways. Trends. Pharmacol. Sci. 27:345-347. (Pubitemid 43963182)
57. Hotamisligil, G. S., P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95:2409-2415.
58. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman (1993) Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:87-91. (Pubitemid 23036092)
59. Fried, S. K., D. A. Bunkin, and A. S. Greenberg (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83:847-850. (Pubitemid 28496456)
60. Mohamed-Ali, V., S. Goodrick, A. Rawesh, D. R. Katz, J. M. Miles, J. S. Yudkin, S. Klein, and S. W. Coppack (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82:4196-4200. (Pubitemid 27525539)
61. Straub, R. H., H. W. Hense, T. Andus, J. Scholmerich, G. A. Riegger, and H. Schunkert (2000) Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: A population-based study. J. Clin. Endocrinol. Metab. 85:1340-1344. (Pubitemid 32269398)
62. Muller, S., S. Martin, W. Koenig, P. Hanifi-Moghaddam, W. Rathmann, B. Haastert, G. Giani, T. Illig, B. Thorand, and H. Kolb (2002) Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45:805-812.
63. Kado, S., T. Nagase, and N. Nagata (1999) Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta. Diabetol. 36:67-72.
64. Fasshauer, M., S. Kralisch, M. Klier, U. Lossner, M. Bluher, J. Klein, and R. Paschke (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 301:1045-1050. (Pubitemid 36279218)
65. 2-induced genotoxicity in mice: Micronuclei occurrence and chromosomal aberration. Arch. Pharm. Res. 28:1079-1085. (Pubitemid 41426856)
66. Kim, H. M., S. H. Hong, S. J. Yoo, K. S. Baek, Y. J. Jeon, and S. Y. Choung (2006) Differential effects of chitooligosaccharides on serum cytokine levels in aged subjects. J. Med. Food. 9:427-430.
67. Harp, J. B. (2004) New insights into inhibitors of adipogenesis. Curr. Opin. Lipidol. 15:303-307. (Pubitemid 38716563)
68. Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman (2000) Transcriptional regulation of adipogenesis. Genes. Dev. 14:1293-1307. (Pubitemid 30397073)
69. Juvet, L. K., S. M. Andresen, G. U. Schuster, K. T. Dalen, K. A. Tobin, K. Hollung, F. Haugen, S. Jacinto, S. M. Ulven, K. Bamberg, J. A. Gustafsson, and H. I. Nebb (2003) On the role of liver X receptors in lipid accumulation in adipocytes. Mol. Endocrinol. 17:172-182. (Pubitemid 36187394)
70. Seo, J. B., H. M. Moon, W. S. Kim, Y. S. Lee, H. W. Jeong, E. J. Yoo, J. Ham, H. Kang, M. G. Park, K. R. Steffensen, T. M. Stulnig, J. A. Gustafsson, S. D. Park, and J. B. Kim (2004) Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol. Cell. Biol. 24:3430-3444. (Pubitemid 38455438)
71. Tamori, Y., J. Masugi, N. Nishino, and M. Kasuga (2002) Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51:2045-2055. (Pubitemid 34729007)
72. Fajas, L., J. C. Fruchart, and J. Auwerx (1998) Transcriptional control of adipogenesis. Curr. Opin. Cell. Biol. 10:165-173. (Pubitemid 28174758)
73. Rousseau, V., D. J. Becker, L. N. Ongemba, J. Rahier, J. C. Henquin, and S. M. Brichard (1997) Developmental and nutritional changes of job and PPAR gamma 2 gene expression in rat white adipose tissue. J. Biochem. 321:451-456. (Pubitemid 27056494)
74. Gregoire, F. M., C. M. Smas, and H. S. sul (1998) Understanding adipocyte differentiation. Physiol. Rev. 78:783-809. (Pubitemid 28340604)
75. Kim, J. B. and B. M. Spiegelman (1996) ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes. Dev. 10:1096-1107. (Pubitemid 26152851)
76. Tontonoz, P., J. B. Kim, R. A. Graves, and B. M. Spiegelman (1993) ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13:4753-4759.
77. Tabor, D. E., J. B. Kim, B. M. Spiegelman, and P. A. Edwards (1999) Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J. Biol. Chem. 274:20603-20610.
78. Hsu, C. L. and G. C. Yen (2007) Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J. Agric. Food. Chem. 55:8404-8410.
79. Yang, J. Y., M. A. Della-Fera, S. Rayalam, S. Ambati, D. L. Hartzell, H. J. Park, and C. A. Baile (2008) Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 82:1032-1039.
80. Margareto, J., E. Larrarte, A. Marti, and J. A. Martinez (2001) Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARgamma and aP2 genes in adipose tissue: Possible features of the antiobesity effects of a beta3-adrenergic agonist. Biochem. Pharmacol. 61:1471-1478. (Pubitemid 32476902)
81. Lee, Y. S., W. S. Kim, K. H. Kim, M. J. Yoon, H. J. Cho, Y. Shen, J. M. Ye, C. H. Lee, W. K. Oh, C. T. Kim, C. Hohnen-Behrens, A. Gosby, E. W. Kraegen, D. E. James, J. B. Kim (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulinresistant states. Diabetes 55:2256-2264. (Pubitemid 44743622)